Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

BUY
$141.59 - $168.66 $21,521 - $25,636
152 New
152 $24,000
Q4 2020

Feb 04, 2021

SELL
$140.71 - $165.05 $14,352 - $16,835
-102 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$105.46 - $144.13 $10,756 - $14,701
102 New
102 $15,000
Q2 2020

Aug 06, 2020

SELL
$95.68 - $121.88 $574 - $731
-6 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$87.74 - $152.74 $263 - $458
3 Added 100.0%
6 $1,000
Q3 2019

Nov 01, 2019

SELL
$125.18 - $143.24 $125 - $143
-1 Reduced 25.0%
3 $0
Q2 2019

Aug 08, 2019

BUY
$125.55 - $144.48 $125 - $144
1 Added 33.33%
4 $1,000
Q1 2019

May 10, 2019

BUY
$121.81 - $142.95 $365 - $428
3 New
3 $0

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Glassman Wealth Services Portfolio

Follow Glassman Wealth Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.